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5-Methoxysalicylic acid (MSA) is demonstrated to be a useful matrix for matrix-assisted laser
desorption/ionization time-of-flight (TOF) mass spectrometry of oligonucleotides, when
desorption/ionization without fragmentation is desired. When MSA is combined with the
additive spermine, the need for desalting is reduced. The MSA/spermine matrix yields linear
TOF mass spectra with improved resolution, less fragmentation, and less intense alkali ion
adduct peaks than those spectra obtained using 3-hydroxypicolinic acid and 6-aza-2-thiothy-
mine with spermine or diammonium hydrogen citrate as additives. Instrumental conditions
are discussed to improve the spectral resolution, specifically the use of longer delay times in
the delayed-extraction ion source. (J Am Soc Mass Spectrom 2001, 12, 456–462) © 2001
American Society for Mass Spectrometry
Matrix-assisted laser desorption/ionizationmass spectrometry (MALDI MS), developedby Karas et al. [1], has been extensively used
to analyze biological compounds at the subpicomole
level. To date, most of the published MALDI MS work
has involved the analysis of peptides and proteins.
MALDI MS has also been used for the analysis of
oligonucleotides [2, 3]. The development of MALDI
matrices optimized for the analysis of oligonucleotides
has lagged behind that for peptides [4], but is currently
receiving considerable attention. This report discusses
the performance of 5-methoxysalicylic acid, with
spermine as a matrix additive, for the detection of
oligonucleotides in MALDI with the suppression of
prompt fragmentation in the linear time-of-flight (TOF)
MS experiment.
Oligonucleotides and DNA behave very differently
than peptides and proteins in the MALDI experiment.
Differences of note include the sensitivity, extent of
prompt fragmentation, the need for cleanup prior to
analysis, and resolution.
Certainly, for all classes of biomolecules studied by
MALDI, as sample handling methods and TOF instru-
ments have been developed, typical sample sizes used
for analysis have decreased. Peptide analysis at the
subpicomole level was rapidly achieved, although it has
taken longer to realize similar MALDI detection limits
for oligonucleotides. There have been significant ad-
vances from earlier reports of MALDI analyses of
oligonucleotides, in which 10–100 pmol of material
were required, to recent reports that show clear detect-
ability at the femtomole level [5, 6].
When a pure peptide is analyzed by MALDI-TOF
MS, it usually yields a single mass spectrometric peak
representing the intact molecule (in protonated or dep-
rotonated form). Matrices and sample conditions have
been reported to increase the extent of prompt fragmen-
tation of peptides in MALDI [7], but experimentalists
have little predictable control over the process, gener-
ally. In contrast, oligonucleotides frequently fragment
promptly and extensively in linear TOF MS [8].
The analysis of pure samples certainly makes mass
spectral interpretation easier for all biomolecules. De-
pending on whether compounds are isolated from
biological sources, from electrophoresis experiments
(gels or membranes), or are synthesized, peptides and
oligonucleotides may be presented for mass spectro-
metry analysis in the presence of compounds such as
salts, buffers, and glycerol, frequently in higher relative
amounts than the analytes. In all cases, high amounts of
salts can sufficiently change the MALDI target material
to lower analyte signals. Glycerol is usually a problem
as a component when the first step of the MALDI
experiment is to grow crystals. In terms of the spectra
that result, salts have a very different impact when
analyzing peptides compared to oligonucleotides. If
NaCl is present, two peaks may appear representing a
single peptide in positive ion mode, most frequently
representing the [M 1 H]1 and [M 1 Na]1 ions, sepa-
rated by 22 Da. As the salt contribution increases,
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sodium adducts become more intense. The presence of
salts has a much more dramatic influence on the
MALDI spectra of oligonucleotides. With an ionic phos-
phodiester backbone, oligonucleotides can contain a
large number of anionic sites that must combine with an
assortment of cationic species such as H1, Na1, and K1
to desorb in a singly charged form. Combinations of
cations to provide a charge balance can lead to a
substantial number of peaks representing the intact
molecule. Whenever ions for a single species are gen-
erated with a range of m/z values, detection limits are
lowered. Also, it becomes much more difficult to detect
multiple components of similar mass. Certainly, a sim-
ple situation is to generate one mass spectral peak per
component, not several.
In the analysis of oligonucleotides with MALDI TOF
MS, the resolution achieved is often less than what
would be realized for peptides of similar size. Adduct
formation and nucleotide base loss have frequently
been cited as causes of the reduced resolution [9]. For
larger oligonucleotides, this is clearly the case. How-
ever, even for smaller sequences with resolved sodium
and potassium adducts, resolution for an oligonucleo-
tide is less than that obtained for a peptide of similar
mass on the same instrument. The use of an ion reflector
does not dramatically improve the resolution of oligo-
nucleotides in MALDI MS [10]. One of the few instances
in which relatively small oligonucleotides were ana-
lyzed by MALDI and spectra containing isotopic reso-
lution were obtained was recently published, using a
MALDI TOF instrument with an extended flight tube
[11]. We show that, for the TOF instrument used in this
work utilizing gridded ion optical components and
delayed extraction (DE), “nontraditional” ion source
settings can improve the resolution.
Although peptides and oligonucleotides have many
differences in terms of their MALDI MS analysis, they
also have some notable similarities in terms of the
development of the analytical utility of mass spectro-
metry for their analysis. Early in the history of MALDI,
demonstrations of the ability to generate signals from
large, intact, ionized proteins maintained excitement for
this new method, allowing it to be further developed.
Whereas positive results had been reported for proteins
with molecular weights (MW) of several hundred thou-
sand, the mass spectral peaks were very broad, and it
was difficult to extract what would be considered in
mass spectrometry an accurate mass. The early results
showed that, in most cases, MW’s determined were
more useful than those derived from gel electrophore-
sis. Today, the real strength of MALDI in protein
analysis does not lie in its ability to generate ions of
intact proteins, but in the subpicomolar sensitivity
obtainable for smaller peptides. The analysis of enzy-
matic and chemical digestion products is the applica-
tion that is making the real contributions to protein
analysis. Scientists have certainly worked to demon-
strate that large oligonucleotides can be characterized
by MALDI as well. Whereas a few reports have been
published demonstrating the detection of 50-mers, the
MALDI response is much more sharply a function of
MW than is observed for peptides, making the detection
of large oligonucleotides far from routine. Because a
potential application was the use of mass spectrometry
to replace gel electrophoresis when sequencing DNA
using the Sanger method, the requirement of the mass
spectrometry method was different than when sequenc-
ing peptides. Peaks with good resolution must be
detectable not only at low m/z values, but over a very
wide mass range, because the approach for DNA anal-
ysis is a ladder sequencing method. Although mass
spectrometry may not in the near future replace gels for
DNA sequencing, other powerful applications are
emerging, notably the analysis of single nucleotide
polymorphisms (SNPs) [12, 13]. In this area, mixtures of
small oligonucleotides, usually with molecular weights
less than 6000 Da, are generated which are indicative of
errors in genetic code. This is an application to which
MALDI MS is well suited. Certainly, the need continues
to develop methods for improved analysis of oligonu-
cleotides of all sizes. The SNP application is clearly
driving method development for analyses of oligonu-
cleotides of sizes for which the challenges are not the
creation of new instruments, but improved matrix
chemistry. The goals continue to be lower detection
limits, the ability to perform analyses with less or no
cleanup (recognizing the contaminants most commonly
encountered, and that purification steps always lead to
sample loss), and to identify experimental conditions in
which fragmentation is decreased or eliminated. Cer-
tainly, in the analysis of mixtures, if one could rely on
generating only one peak per component, as is common
for peptides, then the analysis of mixtures of oligonu-
cleotides would be much easier.
Many matrices have been developed for peptide
analysis [14, 15] by MALDI such as nicotinic acid,
ferulic acid, sinapinic acid, and 2,5-dihydroxybenzoic
acid. Because, generally, these are not as useful for
oligonucleotide analysis, alternate matrices have been
identified [16, 17]. Several matrices were found to be
compatible for the analysis of oligonucleotides using
UV lasers, including 3-hydroxypicolinic acid (HPA) [18]
and 6-aza-2-thiothymine (ATT) [19]. Since the develop-
ment of these matrices, HPA has become the standard
matrix for the analysis of larger nucleic acids while ATT
is used for sequences containing less than 25 bases [2].
In addition to UV-MALDI, work has been done using
infrared lasers [20, 21]. Successful matrices for IR-
MALDI include succinic acid and urea [22]. Because
matrix selection alone does not overcome some of the
problems associated with the MALDI MS analysis of
oligonucleotides, a number of matrix additives have
been developed. The utility of ammonium salts has
been demonstrated to reduce the formation of alkali ion
adducts. Ammonium acetate was the first to be used in
the MALDI experiment [8]. Since then, other ammo-
nium salts have appeared in the literature with the most
successful being diammonium hydrogen citrate [23, 24].
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Thus, if an oligonucleotide exists in solution in polyan-
ionic form as Pn2, it forms a singly charged anion by
adding combinations of H1, Na1, and K1 ions. If NH4
1
ions are present, these compete effectively with alkali
ions in complexing with negatively charged phos-
phates. During the desorption/ionization process, am-
monia is lost, leaving protons behind. In this paper, the
fully protonated form of an oligonucleotide, [Pn2 1
nH1], the “free acid form,” will be referred to as M. If
no alkali ions are involved and all of the phosphates are
neutralized by protons, negative ion MALDI yields
deprotonated molecules, designated as [M 2 H]2. In
our lab, the role of polyamines as matrix additives has
been explored and spermine was found to improve
MALDI spectra for single-stranded oligonucleotides,
eliminating both the need for ammonium citrate as well
as desalting [5, 25].
We demonstrate here that 5-methoxysalicylic acid
(MSA) is useful in the MALDI analysis of oligonucleo-
tides. In our experiences, it is unique in generating
intact oligonucleotide ions with very little fragmenta-
tion. MSA is not a new matrix in the field of MALDI. It
has been suggested that a mixture of MSA, 2,5-dihy-
droxybenzoic acid, and fucose is a useful matrix for the
analysis of peptides [26], whereas MSA with 9-anthra-
cenecarboxylic acid has been demonstrated as a matrix
for the analysis of polymers [27]. MSA has also been
used in a multicomponent matrix when quantitation
was being attempted [28]. We show here that MSA is
also an effective matrix for the analysis of oligonucleo-
tides. The MALDI spectra obtained using MSA are
compared here to those obtained using the traditional
HPA and ATT matrices. Best results were obtained
using spermine as an additive, rather than diammo-
nium hydrogen citrate.
Experimental
The 12-mer oligodeoxyribonucleotide d(CGCGAAT-
TCGCG) was purchased from the Michigan State Uni-
versity Macromolecular Structure, Sequencing, and
Synthesis Facility (East Lansing, MI). The stock solution
used had a concentration of 46.6 pm/mL and was used
without desalting. The matrices 6-aza-2-thiothymine
and 5-methoxysalicylic acid were purchased from Al-
drich (Milwaukee, WI). Spermine and 3-hydroxypico-
linic acid were purchased from Fluka (Milwaukee, WI).
All matrices were used without further purification.
When spermine was used as a matrix additive, it was
prepared at a concentration of 25 mM in water. When
diammonium hydrogen citrate (J.T. Baker, Phillipsburg,
NJ) was used, it was prepared at a concentration of 50
mM in water. Saturated matrix solutions were made
using a 1:1 acetonitrile/additive solution. Samples were
prepared by mixing 1 mL of analyte solution with 1 mL
of the matrix solution on a gold sample plate and
allowing the mixture to air dry.
MALDI mass spectra were recorded using an Applied
Biosystems (Framingham, MA) Voyager delayed ex-
traction linear time-of-flight mass spectrometer
equipped with a nitrogen laser (337 nm, 3 ns pulse). For
the negative ion MALDI spectra reported here, the
accelerating voltage was 215 kV, the delay time was
700 ns, the grid voltage was 94.5% of the accelerating
voltage, and magnitude of the guide wire voltage was
0.20% of the accelerating voltage. Typically, 50 laser
shots were averaged for each spectrum.
UV/visible spectra of aqueous solutions of the ma-
trices were recorded using an ATI Unicam (Cambridge,
UK) UV2 spectrophotometer. All spectra were acquired
with a scan speed of 120 nm/min, a data interval of 0.5
nm, and a 2.0 nm bandwidth. Spectra were acquired for
three matrices, each at a concentration of 2.0 3 1025 M.
Quartz cuvettes were used with water in the reference
cuvette.
Results and Discussion
To demonstrate the advantages of MSA as a MALDI
matrix for oligonucleotide analysis, we selected the
Dickerson dodecamer, d(CGCGAATTCGCG), referred
to here as DD, as an example of a typical oligonucleo-
tide. We have obtained similar results for a variety of
other oligonucleotides, including d(ACCCAC-
CCACCC), d(AAAAACCAAAAA), d(TTTTTG-
GTTTTT), and d(CCGGAATTGGCC). DD was chosen
as an example, because it has been used extensively in
the literature, and contains all four bases. Furthermore,
while all of these oligonucleotides fragment in typically
used matrices such as ATT, DD fragments most exten-
sively. The nomenclature suggested by McLuckey [29]
is used to identify fragment ions.
Data are shown for the analysis of DD using the
three matrices HPA, ATT, and MSA. Their structures
are shown in Figure 1. Using the traditional additive,
diammonium hydrogen citrate (DHC), these three ma-
trices yield the spectra shown in Figure 2. The ATT/
DHC mixture yields the complex spectrum shown in
Figure 2a. The resolution for the peak representing the
deprotonated molecule at m/z 3645 is low, and extensive
Figure 1. Structures of the matrices and additives used in this
study.
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fragmentation occurs. The y8 and w8 peaks, which are
more intense than that for the deprotonated molecule,
are formed following phosphodiester bond cleavage
between the G and A nucleosides. In contrast, the
HPA/DHC matrix produces a much different MALDI
spectrum, Figure 2b. The deprotonated molecule is the
dominant peak in the spectrum, with only small frag-
ment ion peaks present. In comparing Figure 2a, b, the
fragment ions do not change when the matrix is
changed, but HPA produces fewer fragment ions. The
resolution for the deprotonated molecule peak is clearly
higher than in the ATT/DHC spectrum. At m/z values
above m/z 3645, a series of sodium ion adducts are
observed, in which an H1 is replaced by a sodium ion
in the mono-anion. The low mass shoulder on the m/z
3689 peak ([M 2 3H1 1 2Na1]2) is a potassium ad-
duct, [M 2 2H1 1 K1]2.
The spectrum obtained using MSA/DHC as the
matrix, shown in Figure 2c, closely resembles that
obtained using HPA/DHC. There are fewer detectable
fragment ions in Figure 2c and the peaks are less
intense, compared to those in Figure 2a, b. Again, the
change in matrix does not yield a substantial change in
the fragmentation pattern, but changes the extent of
fragmentation. The deprotonated molecule peak is
again the most intense in the spectrum. It is interesting
to note that the potassium adduct has greater intensity
than the monosodium adduct. In Figure 2c, alkali ion
adducts contribute to the unresolved high m/z “tail.”
Although the addition of ammonium citrate reduces
cation adduction, there is still a need for desalting. The
ammonium citrate clearly works more efficiently when
used with HPA or MSA, and does provide spectra that
are superior to those obtained using the matrices alone.
Clearly, the choice of matrix (as well as the choice of
additive [30]) has a substantial impact on the extent of
fragmentation, with MSA allowing for desorption of
intact oligonucleotides with minimal formation of frag-
ment ions. A reduction of fragmentation accompanied
by formation of an intense peak representing the dou-
bly charged molecular ion has also been seen using
3-HPA, at an excititation wavelength of 355 nm [31].
In our experience, spermine is found to be consis-
tently superior to ammonium citrate as a matrix addi-
tive. As shown in Figure 3, the choice of matrix affects
the performance of spermine as an additive. The nega-
tive ion MALDI spectrum obtained using ATT/sperm-
ine as the matrix. Figure 3a, yields a fragmentation
pattern similar to that seen using DHC as an additive,
Figure 2a. Regardless of the additive, fragment ions are
more abundant than the deprotonated molecule. With
spermine as the additive, the resolution of the [M 2
H]2 peak increases, and only small sodium and potas-
sium adduct peaks are present. In addition to the alkali
ion adducts, there are two small higher-m/z peaks that
represent a matrix and a spermine adduct. This is not
the case in the HPA/spermine spectrum shown in
Figure 3b. Although the fragmentation is minimal, the
spermine adduct becomes a dominant peak in the
spectrum. Spermine is ineffective in eliminating the
formation of alkali ion adducts in HPA for this experi-
ment. The five sodium adducts in the m/z range 3667–
3755 increased in intensity from those observed when
HPA/DHC is the matrix. Adduct ions are also formed
in which both spermine and alkali ions are attached.
When combined with spermine, MSA is an ideal
matrix for the desorption/ionization of intact oligonu-
cleotides, as shown in Figure 3c. The spectrum obtained
using the MSA/spermine matrix contains very small
w8–w10 and y8 fragment ions. The peak representing the
intact analyte is fully resolved with the sodium and
potassium adducts greatly reduced. The spermine ad-
duct is of low intensity compared to the intact, depro-
tonated molecule. Also, there is no peak representing
the doubly deprotonated molecule as seen previously in
other spectra of oligonucleotides containing negligible
fragmentation [31]. Thus, if the goal is to obtain spectra
in which one oligonucleotide yields a single peak, MSA
will limit fragmentation and spermine will limit the
formation of adducts, and this combination of MSA and
spermine retains the favorable properties of each matrix
component. The performance of spermine has been
discussed previously and it is not our intention to
reintroduce it here. We do note that the oligonucleotide
samples were used as supplied from the Michigan State
University Macromolecular Structure, Sequencing, and
Synthesis Facility. As synthesized, using standard
methods [32], these samples had a high, but poorly
defined salt content, and contained other contaminants
Figure 2. MALDI-MS negative-ion mass spectra of DD with
DHC as an additive using (a) ATT, (b) HPA, and (c) MSA. Figure 3. MALDI-MS negative-ion mass spectra of DD with
spermine (S) as an additive using (a) ATT, (b) HPA, and (c) MSA.
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such as a buffer. For oligonucleotides made in this way,
desalting is unnecessary if spermine is used.
The spectra in Figures 2 and 3 were obtained using
47 pmol of oligonucleotide as the analyte. With this
amount, the spectra are strong and the differences can
be clearly documented. The MSA/spermine combina-
tion allows for spectra to be obtained with sample
amounts below 1 pmol. Figure 4 shows a portion of the
spectrum obtained using the MSA/spermine combina-
tion with a total of 10 fmol of DD in the target. A
signal-to-noise ratio of 12:1 is achieved (prior to
smoothing).
The results presented here clearly show that matrix
selection can have a dramatic influence on the extent of
fragmentation of oligonucleotides. For the three matri-
ces studied, MSA and HPA are both organic acids, and
ATT is considered as a neutral matrix. If ATT were
drawn in the enol form, all three would have aromatic
hydroxy groups that could be the source of protons for
analyte ionization in the positive ion MALDI experi-
ment. Rather than considering structural features such
as specific functional groups, there may be a correlation
between matrix performance and molar absorptivities.
The UV/visible spectra of equimolar aqueous solutions
of the three matrices used in this work are shown in
Figure 5. As suggested by their spectra, MSA has the
greatest molar absorptivity at 337 nm with a value of
2240 M21 cm21. ATT and HPA have molar absorptivi-
ties at 337 nm of 1135 and 911 M21 cm21, respectively.
Although the UV experiment was conducted in solu-
tion, we expect a similar result for the solid matrices.
This is reflected in the fact that, when MSA is used as a
matrix, significantly lower laser powers are required to
generate intense signals. If a matrix is an efficient “light
harvester,” with a high molar absorptivity, absorbing
crystals may quickly achieve higher temperatures than
would crystals of molecules with lower extinction coef-
ficients. Because the matrix molecules absorb the en-
ergy, time is required for energy to flow from matrix
molecules into analyte molecules [33]. At higher tem-
peratures, desorption rates increase, decreasing the
time in which energy can flow into the analyte. The
result would be less prompt fragmentation. This is one
possible explanation for the reduced fragmentation
observed when MSA is used. With the data provided
here, our intention is not to develop predictive capabil-
ities for fragmentation of oligonucleotide ions as a
function of matrix choice, but rather to establish that
fragmentation is greatly reduced by use of the MSA/
spermine matrix combination.
Whenever new matrices are proposed, the question
of sample spot homogeneity should be addressed. For-
mation of MSA crystals is visibly different than for ATT
and HPA. The MSA solution, applied to a MALDI plate,
tends to spread more than other matrices, yielding a
thinner, more uniform bed of crystals. Spectra such as
those shown can be obtained at most points across the
target, unlike the other matrices for which the crystal
growth is more extensive around the outer edges of the
target.
All of the spectra shown were obtained with what
we consider to be “nontraditional” tuning of the
MALDI DE-TOF instrument used for this work. The PE
Biosystems TOF mass spectrometer uses a “gridded”
ion source and a linear TOF mass analyzer; changes in
voltages suggested here may not have the same effect
on spectra obtained using instruments that do not
employ grids. If analyzing a peptide with a molecular
weight in the 3000–4000 range, an accelerating voltage
of 20 kV, a grid voltage of 94%–95% the accelerating
voltage, a guide wire voltage of approximately 0.05%,
and a delay time of 100 ns are the typical conditions
selected for optimal resolution. Using these conditions,
the resolution obtained for an oligonucleotide is much
less than that for a peptide of similar mass. The reduc-
tion in resolution for oligonucleotides could result from
a number of causes including ion fragmentation in the
ion source during acceleration, and slow desorption/
ionization-kinetics following laser irradiation. Frag-
mentation which occurs on a time scale longer than the
ion generation and shorter than the acceleration time
will be manifested in a linear TOF experiment as tails on
the fragment ion peaks towards higher m/z values [34].
However, the spectra shown here have negligible tail-
ing on the fragments peaks and more prominent tailing
on the peak correlating to the intact ion. Processes other
than fragmentation during acceleration must occur
which lead to the decreased resolution in an oligonu-
cleotide spectrum. The slow desorption/ionization ki-
Figure 4. MALDI-MS negative-ion mass spectrum of 10 fmol of
DD, using MSA/spermine as the matrix.
Figure 5. UV-visible spectra of the matrices. For each, the
concentration (aqueous) was 2.0 3 1025 M.
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netics for an oligonucleotide may be another cause of
decreased resolution. Oligonucleotides are more polar
than peptides or proteins and, thus, require more en-
ergy to generate intact, gas phase ions [10]. Increasing
the delay time is one way to compensate for the
processes that may lead to low resolution. Improve-
ments in resolution as a function of tuning are not
unique to the one instrument on which these experi-
ments were performed. Improvements were also ob-
served on a PerSeptive Biosystems Voyager STR DE
instrument. A portion of the DD spectrum obtained
using MSA/spermine and the standard tuning is shown
in Figure 6a; the same region of the spectrum, obtained
using a much longer delay time, is shown in Figure 6b.
For longer delay times, slightly higher guide wire
voltages are recommended. This combination results in
much improved resolution. The optimized conditions, a
guide wire voltage of 0.200% and a delay time of 700 ns,
provide improved resolution for all peaks in the spec-
trum in both positive and negative ion modes. This
result is not matrix specific. Although we make this
observation, and routinely use long delay times when
obtaining MALDI spectra of oligonucleotides, there is
no one process that could clearly be linked to the delay
time-resolution correlation. Low resolution for oligonu-
cleotides under standard ion source conditions does not
appear to be due to decomposition of the intact anions
during acceleration, because spectra obtained using
long delay times do not contain fragment ion peaks that
are absent or less intense when short delay times are
used. Desorption kinetics, linked to the unique variety
of charge states of the oligonucleotides that may be
trapped in the matrix, may be very different than those
for peptides that are trapped in predominantly neutral
form.
If the combination of a new matrix and modified
tuning leads to the advantage of increased resolution,
one may expect the improvement to be further realized
by using a reflectron. Again, oligonucleotides behave
very differently than do peptides in MALDI MS [10].
Resolution is much lower for oligonucleotides and the
use of a reflectron does not significantly improve the
resolution [10]. When analyzing DD with each of the
three matrices on a Voyager STR in reflectron mode,
there is no change in resolution. The [M 2 H]2 peak is
smaller and the spectra are worse than if a linear TOF
MS is used. The intensity of the [M 2 H]2 peak may
decrease in reflectron mode because we have delayed
all fragmentation from prompt (in source) to occurring
in the flight tube. If this is the case, a post-source decay
experiment should yield an intense spectrum. This is
not observed. It is possible an electron may be ejected
from the [M 2 H]2 species leaving [M 2 H] in the
flight tube. Whatever the mechanism, best results are
achieved for oligonucleotides in negative mode in a
linear MALDI experiment.
Conclusion
Although HPA/DHC and ATT/DHC are matrix/addi-
tive combinations commonly used for oligonucleotide
analyses, MSA proves to be a superior matrix for
detection of the intact analyte in the 12–20 base pair
range when spermine is used as an additive. The
MSA/spermine matrix provides alkali ion adducts of
low abundance, little fragmentation, and better resolu-
tion when compared to ATT and HPA with either DHC
or spermine. Spermine, when used with MSA, reduces
the need for desalting of oligonucleotide samples.
Although analyses of double-stranded oligonucleo-
tides have been reported with several matrices [21, 22],
such noncovalently bound complexes are still difficult
to routinely detect intact. In most cases, if a double-
stranded oligonucleotide is analyzed using MALDI MS,
peaks representing only the single strands are observed
in the spectrum. Although MSA/spermine is very ef-
fective as a matrix for single strands, it does not allow
for double strands to be detected as intact ions. The
search continues for a matrix that will routinely allow
such noncovalent interactions to remain intact.
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